Information

Complementary medicinal products

Complementary medicinal products encompass homeopathic, anthroposophic and Asian medicinal products. With regard to marketing authorisation, Swissmedic takes into account the fact that the considerable value placed on complementary medicine is anchored within the Swiss Constitution.

Herbal medicinal products

Herbal medicinal products Herbal medicinal products or preparations contain only herbal substances or preparations. Within the framework of the simplified authorisation procedure it is possible, in many cases, to waive the need for separate clinical investigations.

Latest News

16.02.2022

Authorised complementary and herbal medicinal products

This report provides, among other things, an overview of the number of authorisations of complementary and herbal medicines with indication and complementary medicines without indication in 2021.

01.02.2022

Use of titanium dioxide in medicinal products

The pharmaceutical excipient titanium dioxide remains permissible in Switzerland until further notice

01.01.2022

Changes to the guidance document Temporary authorisation of human medicinal products HMV4

Simplification of the procedure for “ex officio" temporary authorisation

01.11.2021

New guidance document: Involvement of patient organisation in assessment of patient information HMV4

The new guidance document is valid with effect from 1 November 2021.

01.09.2021

Update to the forms New authorisation of human medicinal products HMV4 and Variations and authorisation extensions HMV4

Consent to exchange of information for applications in collaboration with Access Consortium and Project Orbis

04.08.2021

Executive Summary - Benchmarking 2021

Comparison of Swiss approval times for human medicines with the EU and the USA

01.07.2021

Revision 1.7.2021 - Updating of KPTPO annexes

mandatory from 1 July 2021

Swissmedic
Division Complementary and herbal medicines
Hallerstrasse 7
3012 Berne
Switzerland
Tel +41 58 462 02 11
Fax +41 58 462 02 12